Skip to main content

Table 5 Average velocity data (m ⋅ s−1)

From: The effects of supplementation with P-Synephrine alone and in combination with caffeine on resistance exercise performance

 

CT

P

S

SCF

Set 1

0.46 ± 0.06

0.49 ± 0.06

0.47 ± 0.06

0.48 ± 0.05

Set 2

0.41 ± 0.05a

0.42 ± 0.07a

0.43 ± 0.07a

0.44 ± 0.07a

Set 3

0.38 ± 0.06ab

0.38 ± 0.07ab

0.38 ± 0.09ab

0.40 ± 0.07ab

Set 4

0.36 ± 0.06ab

0.34 ± 0.07abc

0.35 ± 0.09abc

0.38 ± 0.08abc

Set 5

0.33 ± 0.06abcd

0.33 ± 0.08abc

0.34 ± 0.07abc

0.35 ± 0.08abcd

Set 6

0.33 ± 0.06abcd

0.32 ± 0.07abcde

0.31 ± 0.07abcde

0.34 ± 0.08abcde

Mean

0.38 ± 0.05

0.38 ± 0.06

0.39 ± 0.07

0.40 ± 0.07*

  1. Values are mean ± SD
  2. Key: CT Control protocol, P Placebo treatment, S p-synephrine treatment, SCF p-synephrine plus caffeine treatment
  3. a – P ≤ 0.05 from set 1; b – P ≤ 0.05 from set 2; c – P ≤ 0.05 from set 3; d – P ≤ 0.05 from set 4; e – P ≤ 0.05 from set 5; * - P ≤ 0.05 compared to CT and P